These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 25446834
21. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants. Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E. Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579 [Abstract] [Full Text] [Related]
22. Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children. Pancharoen C, Chotpitayasunondh T, Chuenkitmongkol S, Ortiz E. Southeast Asian J Trop Med Public Health; 2012 May; 43(3):687-98. PubMed ID: 23077849 [Abstract] [Full Text] [Related]
25. Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age. Diaz-Mitoma F, Halperin SA, Tapiero B, Hoffenbach A, Zappacosta PS, Radley D, Bradshaw S, Martin JC, Boslego JW, Hesley TM, Bhuyan PK, Silber JL. Vaccine; 2011 Feb 01; 29(6):1324-31. PubMed ID: 21134456 [Abstract] [Full Text] [Related]
31. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine. Stratton KR, Howe CJ, Johnston RB. JAMA; 1994 May 25; 271(20):1602-5. PubMed ID: 8182813 [Abstract] [Full Text] [Related]
32. Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age. Pietrzyk JJ, Wysocki J, Pejcz J, Galaj A, Majda-Stanislawska E, Käyhty H, Thierry-Carstensen B, Jensen AM. Vaccine; 2008 Sep 26; 26(41):5296-303. PubMed ID: 18675870 [Abstract] [Full Text] [Related]
37. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study. Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, Smith B, MacDonald N. Clin Invest Med; 2002 Dec 26; 25(6):243-51. PubMed ID: 12516995 [Abstract] [Full Text] [Related]